Systematic Literature Review of Economic Evaluations of Treatment Alternatives in Chronic Lymphocytic Leukemia.
László LorenzoviciLászló SzilberhornSzabolcs Farkas-RádulyAndrea Ildiko GasparikAndreea Mihaela PrecupAdél Gyöngyvér NagyCarsten Utoft NiemannTero AittokallioZoltán KalóMarcell CsanádiPublished in: BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy (2023)
As personalized medicine is increasingly gaining recognition, we expect that future economic evaluations will also incorporate new solutions, which are necessary to capture a larger number of genetic and molecular markers and more complex patient pathways with individual patient-level allocation of treatment options and thus economic assessments.